NEW YORK, February 27 – Mike Treble, CEO of NimbleGen, believes that he can do for the microarray market what the PC did for computing, namely develop a technology cheap enough and easy enough to use to allow individuals to make their own high-quality microarrays.

"Our long term strategy over the next two to three years is to produce instruments that will allow core centers to produce their own DNA chips,” Treble told GenomeWeb. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.